Interchangeability of Biosimilars in Ophthalmology

Michael A. Klufas, MD, discusses the significance of interchangeability of biosimilars and being able to substitute biosimilars for reference products, as well as the path to achieving the designation of interchangeability from the FDA.

Related Keywords

Michaela Klufas , ,Biosimilars ,Ophthalmology ,Wet Amd ,Age Related Macular Edema ,Interchangeability ,